Tickers

GPI — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-21 07:20:19.093285 UTC · finished 2026-09-21 07:28:04.452488 UTC

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight for GPI because auto retail is capital intensive, relies heavily on inventory financing (floorplan), and profitability drives the cash generation needed to service debt and fund acquisitions.

Composite Trajectory: Mixed

The annual income statement shows revenue growth (+13.2% YoY) but sharply lower profitability: net income fell 34.7% to $325.2M and diluted EPS dropped 31.4% to $25.24 (10-K 2025-12-31, Consolidated Statements of Operations). The quarterly income statement shows revenue and profit declining: Q2 2026 revenue fell 5.6% YoY to $5,385.1M and net income fell 26.5% to $103.3M (10-Q 2026-06-30, Reported Operating Data — Consolidated; Consolidated Statements of Operations). Cash flow is mixed: annual operating cash flow improved to $694.5M from $586.3M, but YTD 2026 operating cash flow collapsed to $155.0M from $410.3M (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Consolidated Statements of Cash Flows). The balance sheet shows higher leverage (total adjusted leverage ratio 3.30 vs 3.14) and lower total liquidity ($684.2M vs $883.0M), though long-term debt decreased sequentially and equity recovered (10-K 2025-12-31, Covenants; 10-Q 2026-06-30, Covenants; Available Liquidity Resources).

2. Red Flags

  • Goodwill impairment of $93.0M recorded in Q3 2025 and intangible franchise rights impairments of $91.1M in 2025 vs $28.2M in 2024 (10-K 2025-12-31, Critical Accounting Estimates; Consolidated Selected Comparisons).
  • Gross margin compression: consolidated gross margin fell from 16.3% to 16.0% annually and from 16.4% to 16.0% in Q2 (10-K 2025-12-31, Reported Operating Data — Consolidated; 10-Q 2026-06-30, Reported Operating Data — Consolidated).
  • SG&A as a percentage of gross profit rising: 67.2% to 70.3% annually; 69.0% to 72.4% in Q2 (same sources).
  • Net income declining sharply both annually ($498.1M to $325.2M) and quarterly ($140.5M to $103.3M) (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, Consolidated Statements of Operations).
  • YTD operating cash flow dropped 62.2% to $155.0M from $410.3M (10-Q 2026-06-30, Consolidated Statements of Cash Flows).
  • Total liquidity decreased from $883.0M at Dec 2025 to $684.2M at June 2026 (10-K 2025-12-31, Available Liquidity Resources; 10-Q 2026-06-30, Available Liquidity Resources).
  • Share repurchases of $554.8M in 2025 while net income fell 34.7% (10-K 2025-12-31, Share Repurchases and Dividends; Consolidated Statements of Operations).
  • Restructuring charges increased to $28.4M in 2025 from $16.7M in 2024 (10-K 2025-12-31, Consolidated Selected Comparisons).
  • Other interest expense, net rose 29.4% to $182.9M in 2025 (10-K 2025-12-31, Consolidated Selected Comparisons).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Overall Assessment: Annual 2025 revenue grew 13.2% to $22,571.4M but gross margin contracted 30 bps to 16.0% and SG&A rose 16.8% to $2,545.5M, pushing SG&A/gross profit to 70.3% from 67.2% (10-K 2025-12-31, Reported Operating Data — Consolidated). Operating income fell 19.3% to $734.0M and net income dropped 34.7% to $325.2M, partly due to $192.8M in asset impairments (vs $33.0M prior year) (10-K 2025-12-31, Consolidated Statements of Operations; Consolidated Selected Comparisons). Quarterly trends are weaker: Q2 2026 revenue fell 5.6% to $5,385.1M, gross margin fell 40 bps to 16.0%, SG&A/gross profit jumped to 72.4%, operating income fell 19.7% to $203.1M, and net income fell 26.5% to $103.3M (10-Q 2026-06-30, Reported Operating Data — Consolidated; Consolidated Statements of Operations). YTD 2026 shows similar declines: revenue -3.7%, operating income -8.5%, net income -13.1% (10-Q 2026-06-30, Reported Operating Data — Consolidated Six Months; Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Annual 2025 GAAP operating cash flow improved to $694.5M from $586.3M, and adjusted operating cash flow rose slightly to $699.2M from $683.0M (10-K 2025-12-31, Consolidated Statements of Cash Flows; Sources and Uses of Liquidity from Operating Activities). However, YTD 2026 GAAP operating cash flow plunged to $155.0M from $410.3M, and adjusted operating cash flow fell to $210.6M from $350.4M, driven by a $159.4M inventory build and lower net income (10-Q 2026-06-30, Consolidated Statements of Cash Flows; Sources and Uses of Liquidity from Operating Activities). Annual investing cash outflows decreased sharply to $671.3M from $1,282.6M due to lower acquisition spending, while YTD 2026 investing turned positive ($22.2M inflow) on $370.2M of disposition proceeds (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Consolidated Statements of Cash Flows). Financing cash flow shifted to negative annually (-$31.1M vs +$681.1M) and remained negative YTD (-$44.6M vs -$27.2M), reflecting debt repayments and share repurchases (same sources).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total assets grew 5.3% to $10,349.6M at Dec 2025 from $9,824.2M, but equity fell 6.2% to $2,789.1M as treasury stock increased to $2,053.2M from $1,506.2M (10-K 2025-12-31, Consolidated Balance Sheets). Long-term debt rose 25.7% to $3,440.5M from $2,737.9M, increasing the total adjusted leverage ratio to 3.14 (10-K 2025-12-31, Consolidated Balance Sheets; Covenants). By June 2026, cash rose to $164.5M from $32.5M, long-term debt decreased to $3,048.4M, and equity recovered to $2,952.2M (10-Q 2026-06-30, Consolidated Balance Sheets). However, total liquidity fell to $684.2M from $883.0M, the leverage ratio edged up to 3.30, and fixed charge coverage declined to 2.84 from 3.28 (10-Q 2026-06-30, Available Liquidity Resources; Covenants). Inventories remained elevated at $2,759.6M vs $2,741.3M (10-Q 2026-06-30, Consolidated Balance Sheets).

6. Data Gaps

  • Standalone Q1 2026 and Q1 2025 quarterly results (10-Q for 2026-03-31 not provided in detail).
  • Standalone Q3 2025 and Q4 2025 quarterly results (10-Q for 2025-09-30 and 10-K only provide annual totals).
  • Full quarterly trends for 2024 and 2023 to establish pre-2025 quarterly trajectory.
  • Detailed breakdown of "Other interest expense, net" components and floorplan assistance amounts beyond the summary tables.
  • Quantification of the $50M annualized cost savings from U.S. staffing reductions announced in April 2026 (10-Q 2026-06-30, Recent Events) in subsequent financial statements.
  • Specifics on the composition and timing of the $192.8M asset impairments (goodwill vs franchise rights vs fixed assets) beyond the segment totals.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status